Zydus Healthcare Financials

NSE: GERMANREM | BSE: 500156

₹ --

₹ -- (--%)

As on --

Market cap

₹390 Cr

Revenue (TTM)

₹4,242 Cr

P/E Ratio

1.7

P/B Ratio

--

Div. Yield

0 %

Annual
Quarterly

Income Statement ( Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	4,241.50	4,094.60	3,899.50	3,651.20	3,472.00	3,181.90
Total Income	4,568.40	4,403.90	4,143.30	3,797.50	3,551.60	3,243.30
Total Expenditure	2,759.50	2,585.50	2,664.70	2,508.00	2,326.90	2,194.60
EBITDA	1,482.00	1,509.10	1,234.80	1,143.20	1,145.10	987.30
Depreciation	506.50	568.80	572.60	575.20	574.90	569.20
EBIT	975.50	940.30	662.20	568.00	570.20	418.10
Interest	0.30	0.40	0.60	0.60	0.60	5.30
Other Income	326.90	309.30	243.80	146.30	79.60	61.40
Exceptional Items	-17.00	--	--	--	112.70	--
Profit before Tax	1,285.10	1,249.20	905.40	713.70	761.90	474.20
Provision for Tax	195.10	187.10	53.70	-15.50	64.50	247.40
Profit after Tax	1,090.00	1,062.10	851.70	729.20	697.40	226.80

Liabilities ( Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	6,284.20	6,187.70	5,414.00	5,085.90	4,527.10	4,834.10
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	429.60	288.50	378.10	272.40	440.60	395.80
Current Liabilities	1,368.30	1,265.10	1,049.80	1,055.00	957.20	917.60
Total Liabilities	8,285.10	7,911.10	6,974.80	6,438.50	5,924.90	6,147.50

Assets ( Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	4,767.70	4,410.80	5,512.90	4,761.30	3,999.00	3,914.20
Current Assets	3,314.40	3,330.50	1,329.00	1,652.00	1,925.90	2,233.30
Total Assets	8,285.10	7,911.10	6,974.80	6,438.50	5,924.90	6,147.50
Total Debt*	--	--	--	--	--	1.00
Net Current Assets	1,946.10	2,065.40	279.20	597.00	968.70	1,315.70
Contingent Liabilities	115.80	160.00	275.60	75.40	66.20	76.70

Cashflow ( Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	1,288.10	1,197.80	1,116.40	1,114.30	1,074.50	914.10
Cash Flow from Investing Activities	-282.80	-883.60	-602.00	-1,034.60	186.90	-811.50
Cash from Financing Activities	-999.00	-282.90	-508.80	-169.00	-1,007.50	-21.40
Net Cash Inflow / Outflow	6.30	31.30	5.60	-89.30	253.90	81.20

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS ()	5,023.04	4,894.47	3,924.88	3,360.37	3,213.82	1,045.16
Cash EPS ()	7,357.14	7,515.67	6,563.59	6,011.06	5,863.13	3,668.20
Adjusted Book Value ()	28,959.45	28,514.75	24,949.31	23,437.33	20,862.21	17,638.71
Dividend per Share ()	4,620.00	1,305.00	2,350.00	780.00	--	--
Cash Flow per Share ()	5,935.94	5,519.82	5,144.70	5,135.02	4,951.61	4,212.44
Free Cash Flow per Share ()	7,184.33	6,501.38	6,448.39	6,366.82	5,957.14	2,890.32

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	20.61	21.54	17.26	14.86	16.29	10.14
ROE (%)	17.48	18.31	16.22	15.17	16.69	6.10
ROA (%)	13.78	14.57	12.85	11.82	11.55	3.86
EBIT Margin (%)	23.00	22.96	16.98	15.56	16.42	13.14
Net Margin (%)	23.86	24.12	20.56	19.20	19.64	6.99
Cash Profit Margin (%)	37.48	39.55	36.52	35.44	36.64	25.02

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	3.59	5.00	6.80	5.16	9.12	10.99
EBIT Growth (%)	3.74	42.00	16.58	-0.39	36.38	68.79
Net Profit Growth (%)	2.63	24.70	16.80	4.56	207.50	22.99
EPS Growth (%)	2.63	24.70	16.80	4.56	207.50	22.99
Book Value Growth (%)	1.56	14.29	6.45	12.34	18.28	6.21

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	--	--	0.00
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	2.42	2.63	1.27	1.57	2.01	2.43
Quick Ratio	2.10	2.28	0.92	1.16	1.46	1.93
Interest Coverage	4,284.67	3,124.00	1,510.00	1,190.50	1,270.83	90.47

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	5.29	8.25	7.63	7.35	7.29	6.93
Asset Turnover	0.54	0.57	0.59	0.60	0.58	0.54
Receivable days	24.08	28.12	26.48	25.86	24.90	22.86
Inventory Days	38.96	36.85	37.73	47.43	52.43	48.28
Payable days	234.34	255.92	203.09	222.54	240.04	220.65
Cash Conversion Cycle	-171.30	-190.95	-138.89	-149.25	-162.71	-149.51